IMMU-22. PHASE IB IMMUNOTHERAPY CLINICAL TRIAL WITH THE USE OF AUTOLOGOUS DENDRITIC CELLS PULSED WITH AN ALLOGENIC TUMORAL CELL LINES LYSATE IN PATIENTS WITH NEWLY DIAGNOSED DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)

BACKGROUND: Diffuse intrinsic pontine glioma (DIPG) is a lethal condition, and therefore novel approaches are needed. Monocyte-derived dendritic cells (mDCs) pulsed with tumor antigens, as professional antigen-presenting cells, are a promising strategy for immunotherapy of invasive brain tumors. MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Madrid, Andres Morales La, Mora, Jaume, Cruz, Ofelia, Lopez, Vicente Santa-Maria, Perez-Jaume, Sara, Guillen, Antonio, Paco, Sonia, Carcaboso, Angel M, Puerta, Patricia, Salvador, Noelia, Juan, Manuel, Benitez-Ribas, Daniel, Cabezon, Raquel, Flórez-Grau, Georgina, Molero, Mari Carmen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715823/
http://dx.doi.org/10.1093/neuonc/noaa222.378

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715823/
http://dx.doi.org/10.1093/neuonc/noaa222.378

Ejemplares similares